Edition:
United States

Pacific Biosciences of California Inc (PACB.OQ)

PACB.OQ on NASDAQ Stock Exchange Global Select Market

7.28USD
3:59pm EST
Change (% chg)

$-0.03 (-0.41%)
Prev Close
$7.31
Open
$7.32
Day's High
$7.38
Day's Low
$7.27
Volume
257,911
Avg. Vol
636,844
52-wk High
$7.84
52-wk Low
$2.03

Latest Key Developments (Source: Significant Developments)

Pacific Biosciences Of California Says Co And Illumina Continue To Expect The Merger To Be Completed In Mid-2019
Friday, 4 Jan 2019 06:10am EST 

Jan 4 (Reuters) - Illumina Inc ::PACIFIC BIOSCIENCES OF CALIFORNIA INC - CO AND ILLUMINA CONTINUE TO EXPECT THE MERGER TO BE COMPLETED IN MID-2019. - SEC FILING.  Full Article

Pacific Biosciences Pacbio To Pay Illumina $43 Mln if merger terminated
Monday, 5 Nov 2018 05:54pm EST 

Nov 5 (Reuters) - Pacific Biosciences of California Inc ::PACIFIC BIOSCIENCES OF CALIFORNIA SAYS UPON MERGER TERMINATION PACBIO WILL BE OBLIGATED TO PAY ILLUMINA TERMINATION FEE OF $43.00 MILLION - SEC FILING.PACIFIC BIOSCIENCES OF CALIFORNIA - IN CIRCUMSTANCES RELATED TO ANTITRUST APPROVALS, ILLUMINA MAY PAY CO MERGER TERMINATION FEE OF $98.00 MILLION.  Full Article

Pacific Biosciences Of California Inc - QTRLY Loss Per Share $0.19
Thursday, 1 Nov 2018 04:15pm EDT 

Pacific Biosciences of California Inc ::PACIFIC BIOSCIENCES OF CALIFORNIA, INC. ANNOUNCES THIRD QUARTER 2018 FINANCIAL RESULTS.Q3 REVENUE $18.2 MILLION VERSUS I/B/E/S VIEW $22.2 MILLION.PACIFIC BIOSCIENCES OF CALIFORNIA - LOWER MANUFACTURING OUTPUT DURING QUARTER ALSO NEGATIVELY IMPACTED GROSS PROFIT.QTRLY LOSS PER SHARE $0.19.  Full Article

Illumina To Acquire Pacific Biosciences For About $1.2 Bln
Thursday, 1 Nov 2018 04:02pm EDT 

Nov 1 (Reuters) - Illumina Inc ::ILLUMINA TO ACQUIRE PACIFIC BIOSCIENCES FOR APPROXIMATELY $1.2 BILLION, BROADENING ACCESS TO LONG-READ SEQUENCING AND ACCELERATING SCIENTIFIC DISCOVERY.ILLUMINA INC - PROPOSED DEAL FOR PRICE OF $8.00 PER PACIFIC BIOSCIENCES SHARE.ILLUMINA INC - DEAL FOR PRICE OF $8.00 PER PACIFIC BIOSCIENCES SHARE.ILLUMINA INC - ILLUMINA EXPECTS TO CLOSE TRANSACTION IN MID-2019..ILLUMINA INC - DEAL FOR TOTAL ENTERPRISE VALUE OF APPROXIMATELY $1.2 BILLION ON A FULLY DILUTED BASIS..ILLUMINA INC - ALL-CASH TRANSACTION.ILLUMINA INC - AGREEMENT HAS BEEN APPROVED BY BOARD OF DIRECTORS OF ILLUMINA AND PACIFIC BIOSCIENCES.  Full Article

Pacific Biosciences Of California Priced Public Offering Of 14.1 Mln Common Shares At $4.25/Shr
Wednesday, 12 Sep 2018 12:10am EDT 

Sept 12 (Reuters) - Pacific Biosciences of California Inc ::PACIFIC BIOSCIENCES OF CALIFORNIA, INC. ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK.SAYS PUBLIC OFFERING OF 14.1 MILLION COMMON SHARES PRICED AT $4.25PER SHARE.  Full Article

Pacific Biosciences Of California Announces Proposed Public Offering Of Common Stock
Monday, 10 Sep 2018 04:01pm EDT 

Sept 10 (Reuters) - Pacific Biosciences of California Inc ::PACIFIC BIOSCIENCES OF CALIFORNIA, INC. ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK.PACIFIC BIOSCIENCES OF CALIFORNIA INC - INTENDS TO USE NET PROCEEDS FROM OFFERING FOR GENERAL CORPORATE PURPOSES.  Full Article

Pacific Biosciences Posts Favorable Outcome In UK And German Patent Litigation Against Oxford Nanopore
Tuesday, 8 May 2018 05:00pm EDT 

May 8 (Reuters) - Pacific Biosciences of California Inc ::PACIFIC BIOSCIENCES ANNOUNCES FAVORABLE OUTCOME IN UK AND GERMAN PATENT LITIGATION AGAINST OXFORD NANOPORE.PACIFIC BIOSCIENCES OF CALIFORNIA - AS PER OUTCOME, OXFORD NANOPORE WILL REFRAIN FROM OFFERING "2D" SEQUENCING PRODUCTS THROUGH END OF 2023 IN UK & GERMANY.  Full Article

Pacific Biosciences Prevails In Patent Eligibility Ruling
Thursday, 22 Mar 2018 04:34pm EDT 

March 22 (Reuters) - Pacific Biosciences Of California Inc ::PACIFIC BIOSCIENCES PREVAILS IN PATENT ELIGIBILITY RULING AGAINST OXFORD NANOPORE.PACIFIC BIOSCIENCES - U.S. DISTRICT COURT DENIED A MOTION TO DISMISS FILED ON DEC 14, 2017 BY UNIT OF OXFORD NANOPORE TECHNOLOGIES LTD​.  Full Article

Pacific Biosciences Of California Prices Public Offering
Tuesday, 13 Feb 2018 09:00am EST 

Feb 13 (Reuters) - Pacific Biosciences Of California Inc ::PACIFIC BIOSCIENCES OF CALIFORNIA, INC. ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK.SAYS PUBLIC OFFERING OF 12.5 MILLION COMMON SHARES PRICED AT $2.40PER SHARE.  Full Article

Pacific Biosciences Of California Announces Proposed Public Offering Of Common Stock
Monday, 12 Feb 2018 04:01pm EST 

Feb 12 (Reuters) - Pacific Biosciences Of California Inc ::PACIFIC BIOSCIENCES OF CALIFORNIA, INC. ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK.PACIFIC BIOSCIENCES OF CALIFORNIA INC - MAY USE PORTION OF NET PROCEEDS FROM OFFERING TO ACQUIRE OR INVEST IN COMPLEMENTARY BUSINESSES, OTHERS.  Full Article